Emerging role of microRNAs in major depressive disorder: Diagnosis and therapeutic implications

Dialogues in Clinical Neuroscience

Volumn 16, Issue 1, 2014, Pages 43-61

  Dwivedi, Yogesh ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Biomarker; Depression; MiRNA; Neural plasticity; Neurogenesis; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; MESSENGER RNA; MICRORNA; BIOLOGICAL MARKER;

3' UNTRANSLATED REGION; ARTICLE; BIOGENESIS; COPING BEHAVIOR; EARLY LIFE STRESS; GENE CONTROL; HUMAN; IMMOBILIZATION STRESS; MAJOR DEPRESSION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; RNA DEGRADATION; RNA STABILITY; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRANSLATION REGULATION; TREATMENT RESPONSE; ANIMAL; DEPRESSIVE DISORDER, MAJOR; GENETICS;

ANIMALS; BIOMARKERS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MICRORNAS; NEUROGENESIS; NEURONAL PLASTICITY;

EID: 84898884700     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (193)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Broadhead WE, Blazer DG, George LK et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264:2524-2528.
3. Pompili M, Innamorati M, Rihmer Z, et al. Cyclothymic-depressiveanxious temperament pattern is related to suicide risk in 346 patients with major mood disorders. J Affect Disord. 2012;136:405-411.
4. Serafini G, Pompili M, Innamorati M, et al. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J Affect Disord. 2011;129:47-55.
5. Innamorati M, Pompili M, Gonda X, et al. Psychometric properties of the Gotland Scale for Depression in Italian psychiatric inpatients and its utility in the prediction of suicide risk. J Affect Disord. 2011;132:99-103.
6. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200.
7. Leistedt SJ, Linkowski P. Brain, networks, depression, and more. Eur Neuropsychopharmacol. 2013;23:55-62.
8. Ota KT, Duman RS. Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis. 2013;57:28-37.
9. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290-13295.
10. Rajkowska G. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res. 2010;126:397-412.
11. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psych. 2001;58:545-553.
12. Miguel-Hidalgo J, Rajkowska G. Morphological brain changes in depression. Can antidepressants reverse them? CNS Drugs. 2002;16:361-372.
13. Aganova EA, Uranova NA. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol. 1992;22:59-65.
14. Dolan RJ, Bench CJ, Liddle PF, et al. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? J Neurol Neurosurg Psychiatry. 1993;56:1290-1294.
15. Drevets WC, Ongür D, Price JL. Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression. Mol Psych. 1998;3:190-191.
16. Andreasen NC. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science. 1997;275:1586-1593.
17. Honer WG. Assessing the machinery of mind: synapses in neuropsychiatric disorders. J Psychiatry Neurosci. 1999;24:116-121.
18. Toni N, Buchs PA, Nikonenko I, Bron CR, Muller D. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature. 1999;402:421-425.
19. Hajsza T, MacLusky NJ, Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci. 2005;21:1299-1303.
20. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psych. 2000;48:713-714.
21. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psych. 2000;48:791-800.
22. Sala M, Perez J, Soloff P, et al. Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol. 2004;14:393-405.
23. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007;6:219-233.
24. Sackeim HA. Functional brain circuits in major depression and remission. Arch Gen Psychiatry. 2001;58:649-650.
25. Honer WG, Falkai P, Young C, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience. 1997;78:99-110.
26. Bearden CE, Glahn DC, Monkul ES, et al. Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res. 2006;42:139-150.
27. Howland JG, Wang YT. Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res. 2008;169:145-158.
28. Farazi TA, Juranek SA, Tuschl T. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development. 2008;135:1201-1214.
29. D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord. 2002;4:183-94.
30. Schouten M, Buijink MR, Lucassen PJ, Fitzsimons CP. New neurons in aging brains: molecular control by small non-coding RNAs. Front Neurosci. 2012;6:25.
31. Dwivedi Y. Evidence demonstrating role of microRNAs in the etiopathology of major depression. J Chem Neuroanat. 2011;42:142-156.
32. Im HI, Kenny PJ. MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012;35:325-334.
33. Malphettes L, Fussenegger M. Impact of RNA interference on gene networks. Metab Eng. 2006;8:672-683.
34. Stäehler CF, Keller A, Leidinger P, et al. Whole miRNome-wide differential co-expression of microRNAs. Genomics Proteomics Bioinformatics. 2012;10:285-294.
35. Xu J, Li CX, Li YS, et al. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Res. 2011;39:825-836.
36. Choi JK, Yu U, Yoo OJ, Kim S. Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics. 2005;21:4348-4355.
37. Mo WJ, Fu XP, Han XT, et al. A stochastic model for identifying differential gene pair co-expression patterns in prostate cancer progression. BMC Genomics. 2009;10:340.
38. Schratt G. Fine-tuning neural gene expression with microRNAs. Curr Opin Neurobiol. 2009;19:213-219.
39. Hussain MU. Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action. Cell Tissue Res. 2012;349:405-413.
40. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740-744.
41. Mathonnet G, Fabian MR, Svitkin YV, et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science. 2007;317:1764-1767.
42. Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol. 2009;10:141-148.
43. Chendrimada TP, Finn KJ, Ji X, et al. MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007;447:823-828.
44. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931-1934.
45. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A. 2006;103:4034-4039.
46. Kosik KS. The neuronal microRNA system. Nat Rev Neurosci. 2006;7:911-920.
47. Michalak P. RNA world-the dark matter of evolutionary genomics. J Evol Biol. 2006;19:1768-1774.
48. Tardito D, Mallei A, Popoli M. Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs. Expert Opin Investig Drugs. 2013;22:217-233.
49. Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res. 2007;61:24R-29R.
50. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J. 2011;278:1598-1609.
51. Bak M, Silahtaroglu A, Møller M, et al. MicroRNA expression in the adult mouse central nervous system. RNA. 2008;14:432-444.
52. He X, Zhang Q, Liu Y, Pan X. Cloning and identification of novel microRNAs from rat hippocampus. Acta Biochim Biophys Sin (Shanghai). 2007;39:708-714.
53. Olsen L, Klausen M, Helboe L, Nielsen FC, Werge T. MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats. PLoS One. 2009;4:1-7.
54. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401-1414.
55. Kapsimali M, Kloosterman WP, de Bruijn E, et al. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007;8:R173.
56. Choi, PS, Zakhary L, Choi WY, et al. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron. 2008;57:41-55.
57. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350-355.
58. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
59. Miska EA, Alvarez-Saavedra E, Townsend M, et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004;5:R68.
60. Sempere LF, Freemantle S, Pitha-Rowe I, et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5:R13.
61. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissuespecific microRNAs from mouse. Curr Biol. 2002;12:735-739.
62. Yu JY, Chung KH, Deo M, Thompson RC, Turner DL. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res. 2008;314:2618-2633.
63. Smirnova L, Gräfe A, Seiler A, et al. Regulation of miRNA expression during neural cell specification. Eur J Neurosci. 2005;21:1469-1477.
64. He M, Liu Y, Wang X, et al. Cell-type-based analysis of microRNA profiles in the mouse brain. Neuron. 2012;73:35-48.
65. Lugli G, Torvik VI, Larson J, Smalheiser NR. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J Neurochem. 2008;106:650-661.
66. Siegel G, Obernosterer G, Fiore R, et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol. 2009;11:705-716.
67. Natera-Naranjo O, Aschrafi A, Gioio AE, Kaplan BB. Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons. RNA. 2010;16:1516-1529.
68. Lugli G, Larson J, Martone ME, Jones Y, Smalheiser NR. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J Neurochem. 2005;94:896-905.
69. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell. 2008;14:926-939.
70. Presutti C, Rosati J, Vincenti S, Nasi S. Non coding RNA and brain. BMC Neurosci. 2006;(suppl 1):S5.
71. Fiore R, Siegel G, Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta. 2008;1779:471-478.
72. Liu C, Zhao X. MicroRNAs in adult and embryonic neurogenesis. Neuromolecular Med. 2009;11:141-152.
73. Vreugdenhil E, Berezikov E. Fine-tuning the brain: microRNAs. Front Neuroendocrinol. 2009;31:128-133.
74. Jun H, Mohammed Qasim Hussaini S, Rigby MJ, Jang MH. Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders. Neural Plast. 2012;2012:854285.
75. Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: a road to remission? Science. 2012;338:72-75.
76. Alonso M, Viollet C, Gabellec MM, et al. Olfactory discrimination learning increases the survival of adult-born neurons in the olfactory bulb. J Neurosci. 2006;26:10508-10513.
77. Dupret D, Revest JM, Koehl M, et al. Spatial relational memory requires hippocampal adult neurogenesis. PLoS One. 2008;3:e1959.
78. DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology. 2010;58:884-893.
79. Lucassen PJ, Meerlo P, Naylor AS, et al. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action. Eur Neuropsychopharmacol. 2010;20:1-17.
80. Mendez-David I, Hen R, Gardier AM, David DJ. Adult hippocampal neurogenesis: an actor in the antidepressant-like action. Ann Pharm Fr. 2013;71:143-149.
81. Lee MM, Reif A, Schmitt AG. Major depression: a role for hippocampal neurogenesis? Curr Top Behav Neurosci. 2013;14:153-179.
82. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476:458-461.
83. Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci. 2010;33:569-579.
84. Lang MF, Shi Y. Dynamic roles of microRNAs in neurogenesis. Front Neurosci. 2012;6:71.
85. McLoughlin HS, Fineberg SK, Ghosh LL, Tecedor L, Davidson BL. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285-295.
86. Ouchi Y, Banno Y, Shimizu Y, et al. Reduced adult hippocampal neurogenesis and working memory deficits in the DGCR8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J Neurosci. 2013;29;9408-9419.
87. Pathania M, Torres-Reveron J, Yan L, et al. miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS One. 2012;7: e38174
88. Cheng LC, Pastrana E, Tavazoie M, Doetsch F miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12;399-408.
89. Bruno Ig, Karam R, Huang L, et al. Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell. 2011;42:500-510.
90. Åkerblom M, Sachdeva R, Barde I, et al. MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci. 2012;32:8879-8889.
91. Szulwach KE, Li X, Smrt RD, et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol. 2010;189:127-141.
92. Zhang J, Zhang J, Zhou Y, et al. Novel cerebellum-enriched mir-592 may mlay a role in neural progenitor cell differentiation and neuronal maturation through regulating Lrrc4c and Nfasc in rat. Curr Mol Med. 2013;13:1432-1445.
93. Davis TH, Cuellar TL, Koch SM, et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci. 2008;28:4322-4330.
94. De Pietri Tonelli D, Pulvers JM, Haffner C, et al. MiRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development. 2008;135:3911-3921.
95. Schaefer A, O'Carroll D, Tan CL, et al. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med. 2007;204:1553-1558.
96. Olde Loohuis NF, Kos A, Martens GJ, et al. MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci. 2012;69:89-102.
97. Stark KL, Xu B, Bagchi A, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet. 2008;40:751-760.
98. Jin P, Zarnescu DC, Ceman S, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004;7:113-117.
99. Qurashi A, Chang S, Peng J. Role of microRNA pathway in mental retardation. ScientificWorldJournal. 2007;7:146-154.
100. Caudy AA, Myers M, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 2002;16:2491-2496.
101. Ishizuka A, Siomi MC, Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 2002;16:2497-2508.
102. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell. 2006;124:191-205.
103. Wayman GA, Davare M, Ando H, et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A. 2008;105:9093-9098.
104. Edbauer D, Neilson JR, Foster KA, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron. 2010;65:373-384.
105. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microRNA regulates dendritic spine development. Nature. 2006;439:283-289.
106. Meng Y, Takahashi H, Meng J, et al. Regulation of ADF/cofilin phosphorylation and synaptic function by LIM-kinase. Neuropharmacology. 2004;47:746-754.
107. Fiore R, Khudayberdiev S, Christensen M, et al. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 2009;28:697-710.
108. Dwivedi Y, Rizavi HS, Conley RR, et al. Altered gene expression of brainderived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60:804-815.
109. Dwivedi Y, Rizavi H, Zhang H, et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry. 2009;65:319-328.
110. Cohen JE, Lee PR, Chen S, Li W, Fields RD. MicroRNA regulation of homeostatic synaptic plasticity. Proc Natl Acad Sci U S A. 2011;108:11650-11655.
111. Banerjee S, Neveu P, Kosik KS. A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron. 2009;64:871-884.
112. Dwivedi Y, Rao JS, Rizavi HS, et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60:273-282.
113. Vo N, Klein ME, Varlamova O, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 2005;102:16426-16431.
114. Wu J, Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006;7:R85.
115. Impey S, Davare M, Lasiek A, et al. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol Cell Neurosci. 2010;43:146-156.
116. Rajasethupathy P, Fiumara F, Sheridan R, et al. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron. 2009;63:803-817.
117. Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466:1105-1109.
118. Scott HL, Tamagnini F, Narduzzo KE, et al. MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci. 2012;36:2941-2948.
119. Eyman M, Cefaliello C, Ferrara E, et al. Local synthesis of axonal and presynaptic RNA in squid model systems. Eur J Neurosci. 2007;25:341-350.
120. Ju W, Morishita W, Tsui J, et al. Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat Neurosci. 2004;7:244-253.
121. Weiler IJ, Irwin SA, Klintsova AY, et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A. 1997;94:5395-5400.
122. Todd PK, Mack KJ, Malter JS. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci U S A. 2003;100:14374-14378.
123. Sutton MA, Schuman EM. Local translational control in dendrites and its role in long-term synaptic plasticity. J Neurobiol. 2005;64:116.
124. Smalheiser NR. Synaptic enrichment of microRNAs in adult mouse forebrain is related to structural features of their precursors. Biol Direct. 2008;3:44.
125. Budhu A, Ji J, Wang XW. The clinical potential of microRNAs. J Hematol Oncol. 2010;3:37.
126. Serafini G, Pompili M, Innamorati M, et al. The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior. Neurosci Res. 2012;73:179-190.
127. Chana G, Bousman CA, Money TT, et al. Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci. 2013;7:95.
128. Dorval V, Nelson PT, Hébert SS. Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers. Front Mol Neurosci. 2013;6:24.
129. Smalheiser NR, Lugli G, Rizavi HS, et al. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol. 2011;14:1315-1325.
130. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psych. 2001;49:391-404.
131. Vreugdenhil E, Verissimo CS, Mariman R, et al. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology. 2009;150:2220-2228.
132. Uchida S, Nishida A, Hara K, et al. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNAmediated down-regulation of the glucocorticoid receptor. Eur J Neurosci. 2008;27:2250-2261.
133. Turner JD, Alt SR, Cao L, et al. Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochem Pharmacol. 2010;80:1860-1868.
134. Rinaldi A, Vincenti S, De Vito F, et al. Stress induces region specific alterations in microRNAs expression in mice. Behav Brain Res. 2010;208:265-269.
135. Meerson A, Cacheaux L, Goosens KA, et al. Changes in brain microRNAs contribute to cholinergic stress reactions. J Mol Neurosci. 2010;40:47-55.
136. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004;14:461-469.
137. Matigian N, Windus L, Smith H, et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry. 2007;12:815-825.
138. Cao MQ, Chen DH, Zhang CH, Wu ZZ. Screening of specific microRNA in hippocampus of depression model rats and intervention effect of Chaihu Shugan San. Zhongguo Zhong Yao Za Zhi. 2013;38:1585-1589.
139. Raabe FJ, Spengler D. Epigenetic risk factors in PTSD and depression. Front Psychiatry. 2013;4:80.
140. Uchida S, Hara K, Kobayashi A, et al. Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. J Neurosci. 2010;30:15007-15018.
141. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A. 2006;103:2422-2427.
142. Otto SJ, McCorkle SR, Hover J, et al. A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J Neurosci. 2007;27:6729-6739.
143. Pascual R, Zamora-León P, Catalán-Ahumada M, Valero-Cabré A. Early social isolation decreases the expression of calbindin D-28k and dendritic branching in the medial prefrontal cortex of the rat. Int J Neurosci. 2007;117:465-476.
144. Ovtscharoff W Jr, Braun K. Maternal separation and social isolation modulate the postnatal development of synaptic composition in the infralimbic cortex of Octodon degus. Neuroscience. 2001;104:33-40.
145. Stevenson CW, Marsden CA, Mason R. Early life stress causes FG-7142-induced corticolimbic dysfunction in adulthood. Brain Res. 2008;1193:43-50.
146. Bai M, Zhu X, Zhang Y, et al. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One. 2012;7:e46921.
147. Launay JM, Mouillet-Richard S, Baudry A, Pietri M, Kellermann O. Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl Psychiatry. 2011;22:1:e56.
148. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science. 2010;329:1537-1541.
149. O'Connor RM, Grenham S, Dinan TG, Cryan JF. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol. 2013;16:1885-1892.
150. Ryan KM, O'Donovan SM, McLoughlin DM. Electroconvulsive stimulation alters levels of BDNF-associated microRNAs. Neurosci Lett. 2013;549:125-129.
151. Morag A, Pasmanik-Chor M, Oron-Karni V, et al. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker. Pharmacogenomics. 2011;12:171-184.
152. Oved K, Morag A, Pasmanik-Chor M, et al. Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics. 2012;13:1129-1139.
153. Schmidt U, Herrmann L, Hagl K, et al. Therapeutic action of fluoxetine is associated with a reduction in prefrontal cortical miR-1971 expression levels in a mouse model of posttraumatic stress disorder. Front Psychiatry. 2013;4:66.
154. Machado-Vieira R, Salvadore G, DiazGranados N, et al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010;10:713-726.
155. Saus E, Brunet A, Armengol L, et al. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J Psychiatr Res. 2010;44:971-978.
156. Smalheiser NR, Lugli G, Rizavi HS, et al. MicroRNA expression is downregulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One. 2012;7:e33201.
157. Wang J, Cheng CM, Zhou J, et al. Estradiol alters transcription factor gene expression in primate prefrontal cortex. J Neurosci Res. 2004;76:306-314.
158. He Y, Zhou Y, Xi Q, et al. Genetic variations in microRNA processing genes are associated with susceptibility in depression. DNA Cell Biol. 2012;31:1499-1506.
159. Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27-41.
160. Hanke M, Hoefig K, Merz H, et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28:655-661.
161. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733-1741.
162. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
163. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684.
164. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE. 2012;7:e30679.
165. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010;38:7248-7259.
166. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology. 2011;13:423-433.
167. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-5008.
168. Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009;387:303-314.
169. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8:467-477.
170. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148:1172-1187.
171. Wang Q, Wei L, Guan X, et al. Briefing in family characteristics of microRNAs and their applications in cancer research. Biochim Biophys Acta. 2014;1844:191-197.
172. Piva R, Spandidos DA, Gambari R. From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol. 2013;43:985-994.
173. Saito Y, Saito H. MicroRNAs in cancers and neurodegenerative disorders. Front Genet. 2012;3:194.
174. Ceman S, Saugstad J. MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol Ther. 2011;130:26-37.
175. Chan AW, Kocerha J. The path to microRNA: therapeutics in psychiatric and neurodegenerative disorders. Front Genet. 2012;17;3:82.
176. Gaughwin PM, Ciesla M, Lahiri N, et al. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet. 2011;20:2225-2237.
177. Shi W, Du J, Qi Y, et al. Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res. 2012;46:198-204.
178. Rong H, Liu TB, Yang KJ, et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res. 2011;45:92-95.
179. Belzeaux R, Bergon A, Jeanjean V, et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry. 2012;2:e185.
180. Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, et al. Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol. 2013;23:602-611.
181. Mellios N, Sugihara H, Castro J. miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nat Neurosci. 2011;14:1240-1242.
182. Caputo V, Sinibaldi L, Fiorentino A. Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allelespecific binding. PLoS One. 2011;6:e28656.
183. Kawashima H, Numakawa T, Kumamaru E, et al. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience. 2010;165:1301-1311.
184. Kim AH, Reimers M, Maher B, et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res. 2010;124:183-191.
185. Azuma-Mukai A, Oguri H, Mituyama T, et al. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci U S A. 2008;105:7964-7969.
186. Zeng Y, Sankala H, Zhang X, Graves PR. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem J. 2008;413:429-436.
187. Dwivedi Y, Rizavi HS, Roberts RC, et al. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem. 2001;77:916-928.
188. Dwivedi Y, Zhang H, Pandey GN. Calcium sensing proteins in depressive disorder. Am Coll Neuropsychophramacol. 2011;36:S75-S197. Abstract 29.
189. Dwivedi Y, Rizavi HS, Zhang H, et al. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). Int J Neuropsychopharmacol. 2009;12:1337-1354.
190. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry. 2006;11:86-98.
191. Mellios N, Sur M. The emerging role of microRNAs in schizophrenia and autism spectrum disorders. Front Psychiatry. 2012;3:39.
192. Kalani A, Tyagi A, Tyagi N. Exosomes: Mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2013. [Epub ahead of print] PMID:23999871
193. Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14:5338-5366.